Predictors of endovascular treatment failure in heavily calcified lower extremity arterial disease: a vascular surgery perspective
Heavily calcified infrainguinal peripheral artery disease remains a major challenge for endovascular therapy, particularly in patients with chronic limb-threatening ischemia. Despite ongoing advances in endovascular techniques and devices, severe arterial calcification continues to drive procedural failure, early loss of patency, repeated reinterventions, and suboptimal limb outcomes. Accumulating evidence indicates that calcification phenotype—especially circumferential, long-segment, and multilevel involvement—plays a central role in guidewire crossing difficulty, inadequate luminal expansion, recoil, stent underexpansion, and accelerated restenosis, with these risks being most pronounced in infrapopliteal interventions and in patients with diabetes or chronic kidney disease. Although emerging vessel preparation technologies and intravascular imaging guidance have improved procedural performance, angiographic success frequently fails to translate into durable clinical benefit in severely calcified disease. Here, we review recent evidence on the assessment of arterial calcification, its mechanistic links to endovascular treatment failure, and its impact on limb-based outcomes, and we propose a vascular surgery–oriented, calcification-aware framework to support strategy selection, escalation, and timely conversion to hybrid or bypass revascularization to improve durability and limb salvage.
Authors
- 陈湛
- Ruimin Lin
- Hong Sun (ORCID: https://orcid.org/0000-0003-2135-3107)
- Jun Liu (ORCID: https://orcid.org/0000-0001-8148-9175)
- Zhimiao Cui
Institutions
- Beijing Haidian Hospital (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3389/fcvm.2026.1857180
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00